Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2021-03-09 18:59:38
Reporting Period:
Accepted Time:
2021-03-09 18:59:38
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1618835 Evofem Biosciences Inc. EVFM () 4
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1251371 L Saundra Pelletier C/o Evofem Biosciences, Inc.
12400 High Bluff Drive, Suite 600
San Diego CA 92130
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-09 45,249 $2.28 906,137 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
  1. These purchases were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2020.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.21 to $2.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4.